Sorafenib before liver transplantation for hepatocellular carcinoma: risk or give up

Transpl Int. 2011 Nov;24(11):e97; author reply e98-9. doi: 10.1111/j.1432-2277.2011.01329.x. Epub 2011 Sep 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use*
  • Benzenesulfonates / adverse effects*
  • Benzenesulfonates / therapeutic use*
  • Carcinoma, Hepatocellular / drug therapy*
  • Female
  • Humans
  • Liver Neoplasms / drug therapy*
  • Liver Transplantation / methods*
  • Male
  • Pyridines / adverse effects*
  • Pyridines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Pyridines